Cristin Rothfuss - 28 Nov 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
EVP, General Counsel
Signature
/s/ Cristin L. Rothfuss
Issuer symbol
SRPT
Transactions as of
28 Nov 2025
Transactions value $
-$4,836
Form type
4
Filing time
02 Dec 2025, 20:02:03 UTC
Previous filing
05 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rothfuss Cristin EVP, General Counsel 215 FIRST STREET, CAMBRIDGE /s/ Cristin L. Rothfuss 02 Dec 2025 0002046214

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability -$4.84K -229 -0.16% $21.12 140K 28 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 26, 2024.